Diagnostics & Therapeutics in S. aureus

This webinar explores the rapidly evolving landscape of Staphylococcus aureus diagnostics and therapeutics, bringing together three complementary perspectives that span cutting-edge treatment strategies, real-time genomic technologies, and emerging diagnostic approaches for complex infections.

WATCH ON DEMAND

ISAC's Living Legends in Infectious Diseases podcast series

"Living Legends in Infectious Diseases" is a new podcast series from the International Society of Antimicrobial Chemotherapy (ISAC), spotlighting the people whose work has shaped modern infection.

Episode 3: Prof. Shaheen Mehtar

In this episode Ian Gould sits down with Professor Shaheen Mehtar (Stellenbosch University, Cape Town; Founding member and Past Chair, ICAN) to trace her remarkable journey from early training in Pakistan and the UK to shaping IPC across Africa. Through stories of mentorship, global outbreaks, WHO policy work, and building Africa’s first infection-control unit, Mehtar reflects on decades of change in microbiology, AMR, Ebola, COVID, and the challenges of a continent “so huge people underestimate its size.”

Therapy for S. aureus bacteremia: evidence from recent trials and prospects for future research

25 August 2026

This webinar will review current practices and ongoing controversies in the treatment of Staphylococcus aureus bacteremia, a common infection with a persistent 15-30% mortality rate. Leading trial investigators will present recent evidence, highlight unresolved questions, and outline future directions for improving antimicrobial therapy.

REGISTER

ISAC Project Grants - apply by 1 September 2026

Applications are open for ISAC Project Grants, offering up to £15,000 to support antimicrobial chemotherapy research.

Projects must address one of four priority areas, including infection prevention, laboratory capacity, antimicrobial stewardship or communication strategies, and involve at least one investigator from a low- or middle-income country.

Exclusively available to members of ISAC Member Societies.

MORE INFORMATION

Top cited papers

The International Journal of Antimicrobial Agents (IJAA) is pleased to highlight the most cited paper contributing to its 2025 Journal Impact Factor:

Colistin: from the shadows to a One Health approach for addressing antimicrobial resistance
By Mohamed Rhouma, Jean-Yves Madec and Ramanan Laxminarayan

The Journal of Global Antimicrobial Resistance (JGAR) is pleased to highlight the most cited paper contributing to its 2025 Journal Impact Factor:

Contribution of wastewater to antimicrobial resistance: A review article
Shepherd Sundayi Sambaza and Nisha Naicker

Other news…

ISAC / APUA sign G7 call to action

The International Society of Antimicrobial Chemotherapy (ISAC) and the The Alliance for the Prudent Use of Antibiotics (APUA) have joined nearly 50 academic experts, clinicians, patient organisations and industry partners in endorsing a global call to action on antimicrobial resistance (AMR) ahead of France's G7 Presidency.

Published in Le Monde, the call highlights AMR as one of the greatest threats to modern medicine and global health security, urging G7 leaders to make AMR a global priority.

READ MORE

IMPACT-ICU: Infection management and prevention - advances and current trends for intensive care unit patients

28–30 September 2026, Thessaloniki, Greece & Online

ISAC is pleased to endorse this ESCMID Postgraduate Course which will bring together leading international experts to provide the latest evidence and practical guidance on infection prevention, antimicrobial stewardship, diagnostics, sepsis, multidrug-resistant pathogens, fungal infections, and the management of critically ill patients.

REGISTER